Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$4.81 - $6.99 $4,550 - $6,612
-946 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$5.97 - $7.93 $5,647 - $7,501
946 New
946 $6,000
Q2 2021

Jul 26, 2021

SELL
$5.35 - $6.35 $4,280 - $5,080
-800 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$5.68 - $7.87 $4,544 - $6,296
800 New
800 $5,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $351M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.